Trial intelligence / Profile preview

Samidorphan in Adults With Binge Eating Disorder

NCT01098435Phase 2Completed

Sponsor
Alkermes
Start
May 2010
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of samidorphan in binge eating disorder (BED), sponsored by Alkermes. Started May 2010; status: completed.

02

Drugs

samidorphan
03

Conditions

binge eating disorder (BED)

Beyond the preview

Go deeper on NCT01098435.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01098435.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call